Chemed (NYSE:CHE) Updates FY 2021 After-Hours Earnings Guidance

Chemed (NYSE:CHE) issued an update on its FY 2021
After-Hours earnings guidance on Tuesday morning. The company provided EPS guidance of 17.00-17.50 for the period, compared to the Thomson Reuters consensus EPS estimate of $17.28.

NYSE:CHE traded up $4.07 during trading hours on Tuesday, hitting $481.07. 71,869 shares of the stock traded hands, compared to its average volume of 95,473. The firm has a 50 day moving average price of $522.73 and a 200 day moving average price of $502.00. Chemed has a fifty-two week low of $330.01 and a fifty-two week high of $560.00. The firm has a market cap of $7.67 billion, a price-to-earnings ratio of 29.17, a PEG ratio of 2.89 and a beta of 0.55.

The firm also recently disclosed a quarterly dividend, which will be paid on Friday, March 19th. Investors of record on Monday, March 1st will be issued a $0.34 dividend. This represents a $1.36 dividend on an annualized basis and a yield of 0.28%. The ex-dividend date of this dividend is Friday, February 26th. Chemed’s dividend payout ratio is presently 9.75%.

Separately, Zacks Investment Research lowered shares of Chemed from a buy rating to a hold rating and set a $532.00 target price for the company. in a research report on Wednesday, December 16th.

In other Chemed news, Director Donald E. Saunders sold 510 shares of the company’s stock in a transaction dated Friday, December 18th. The shares were sold at an average price of $526.45, for a total transaction of $268,489.50. Following the sale, the director now directly owns 6,226 shares of the company’s stock, valued at $3,277,677.70. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this link. Also, CEO Kevin J. Mcnamara sold 2,000 shares of the company’s stock in a transaction dated Friday, January 8th. The stock was sold at an average price of $549.30, for a total transaction of $1,098,600.00. Following the sale, the chief executive officer now directly owns 140,963 shares in the company, valued at $77,430,975.90. The disclosure for this sale can be found here. Insiders sold 5,010 shares of company stock valued at $2,680,840 in the last three months. Company insiders own 3.96% of the company’s stock.

Chemed Company Profile

Chemed Corporation provides hospice and palliative care services to patients through a network of physicians, registered nurses, home health aides, social workers, clergy, and volunteers in the United States. It operates in two segments, VITAS and Roto-Rooter. The company also offers plumbing, drain cleaning, water restoration, and other related services to residential and commercial customers through company-owned branches and independent contractors, and franchised locations.

Featured Article: What is meant by a buy rating?

Earnings History and Estimates for Chemed (NYSE:CHE)

Receive News & Ratings for Chemed Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Chemed and related companies with MarketBeat.com's FREE daily email newsletter.

Comments


share news on Facebook
tweet this investment news
share on linkedin
share on StockTwits
share on reddit